Regeneron Pharmaceuticals Inc (REGN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.42B | 3.16B | 3.16B | 3.36B | 3.43B | 3.15B | 3.55B | 3.72B |
| Operating Income | 1.05B | 946.7M | 1.02B | 1.11B | 972.9M | 751.4M | 1.07B | 1.18B |
| Pre Tax Income | 1.32B | 858M | 1.08B | 1.11B | 1.15B | 700.7M | 1.63B | 1.49B |
| Net Income | 1.2B | 817.8M | 968.4M | 1.01B | 1.16B | 722M | 1.43B | 1.34B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 1.1B | 876M | 1.03B | 1.13B | 920.7M | 751.5M | 1.07B | 1.18B |
| EBITDA | 1.15B | 1.05B | 1.12B | 1.22B | 1.09B | 865.5M | 1.19B | 1.3B |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.86B | 5.87B | 6.71B | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
| Operating Income | 1.33B | 2.08B | 2.53B | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
| Pre Tax Income | 1.33B | 2.08B | 2.55B | 2.43B | 3.81B | 9.33B | 4.86B | 4.2B |
| Net Income | 895.52M | 1.2B | 2.44B | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 4.178 | 5.324 | 10.705 | 9.492 | 16.246 | 36.757 | 19.582 | 17.951 |
| EBIT | 1.34B | 2.1B | 2.58B | 2.34B | 3.67B | 9B | 4.8B | 4.03B |
| EBITDA | 1.44B | 2.22B | 2.68B | 2.42B | 3.81B | 9.23B | 5.08B | 4.47B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
